Seroepidemiology of hepatitis A virus in Kuwait

Affiliations

07 January 2009

-

doi: 10.3748/wjg.15.102


Abstract

Aim: To find the current seroepidemiology of hepatitis A virus (HAV) in Kuwait.

Methods: A total of 2851 Kuwaitis applying for new jobs were screened.

Results: HAV-positive cases were 28.8%; 59% were males and 41% were females. The highest prevalence was in the Ahmadi area. High prevalence was among the group of non-educated rather than educated parents. This is the first study in Kuwait demonstrating the shifting epidemiology of HAV.

Conclusion: This study reflects the need of the Kuwaiti population for an HAV vaccine.


Figures


Similar articles

Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.

Mossong J, Putz L, Patiny S, Schneider F.Epidemiol Infect. 2006 Aug;134(4):808-13. doi: 10.1017/S0950268805005789. Epub 2006 Jan 25.PMID: 16436219 Free PMC article.

Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.

Jaber SM.Saudi Med J. 2006 Oct;27(10):1515-22.PMID: 17013474

The seroprevalence of hepatitis A and B in people testing positive for hepatitis C.

Kiefer LA, Honish A, Predy G, Talbot JA.CMAJ. 2000 Jan 25;162(2):207-8.PMID: 10674054 Free PMC article. No abstract available.

The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.

Keystone JS, Hershey JH.Int J Infect Dis. 2008 Jan;12(1):3-11. doi: 10.1016/j.ijid.2007.04.012. Epub 2007 Jul 20.PMID: 17643334 Review.

Asian perspectives on viral hepatitis A.

Lee SD.J Gastroenterol Hepatol. 2000 Oct;15 Suppl:G94-9. doi: 10.1046/j.1440-1746.2000.02239.x.PMID: 11101002 Review.


Cited by

Hepatitis A in the Eastern Mediterranean Region: a comprehensive review.

Badur S, Öztürk S, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O, Hanif K, Saha D.Hum Vaccin Immunother. 2022 Nov 30;18(5):2073146. doi: 10.1080/21645515.2022.2073146. Epub 2022 May 26.PMID: 35617508 Free PMC article.

Evidence of Circulation of Several HAV Genetic Variants and Emergence of Potential Antigenic Variants in an Endemo-Epidemic Country before Vaccine Introduction.

Ayouni K, Chouikha A, Khamessi O, Touzi H, Hammemi W, Triki H.Viruses. 2021 Jun 3;13(6):1056. doi: 10.3390/v13061056.PMID: 34204862 Free PMC article.

Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.

Ayouni K, Naffeti B, Ben Aribi W, Bettaieb J, Hammami W, Ben Salah A, Ammar H, Ben Miled S, Triki H.BMC Infect Dis. 2020 Aug 26;20(1):627. doi: 10.1186/s12879-020-05318-7.PMID: 32842988 Free PMC article.

Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study.

Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, Motlagh ME, Qorbani M, Heshmat R, Tajadini MH, Ghaffari Hoseini S.Hepat Mon. 2016 Aug 17;16(9):e36437. doi: 10.5812/hepatmon.36437. eCollection 2016 Sep.PMID: 27822259 Free PMC article.

Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran.

Farajzadegan Z, Hoseini SG, Kelishadi R, Jamshidi F, Nokhodian Z, Noori R, Mirmoghtadaee P, Hovsepian S, Mostafavi SN.J Res Med Sci. 2014 Mar;19(Suppl 1):S56-63.PMID: 25002897 Free PMC article. Review.


KMEL References